These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26069199)

  • 1. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
    Voigtländer T; Jaeckel E; Lehner F; Manns MP; Lankisch TO
    Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.
    Kirchner GI; Scherer MN; Obed A; Ruemmele P; Wiest R; Froh M; Loss M; Schlitt HJ; Schölmerich J; Gelbmann CM
    Scand J Gastroenterol; 2011 Apr; 46(4):471-8. PubMed ID: 21114429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
    Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
    United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Hetzer R; Schaffartzik W; Tryba M; Neuhaus P; Seehofer D
    Crit Care; 2015 Mar; 19(1):131. PubMed ID: 25886728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
    Voigtländer T; Negm AA; Schneider AS; Strassburg CP; Manns MP; Wedemeyer J; Lankisch TO
    Endoscopy; 2012 Nov; 44(11):1055-8. PubMed ID: 23108773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
    Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary sclerosing cholangitis in cardiac surgical patients: A complication with a dismal prognosis.
    Schade I; Radakovic D; Hoffmann J; Sommer SP; Stefenelli U; Schimmer C; Leyh RG; Aleksic I
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):906-912. PubMed ID: 28554673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
    Gossard AA; Angulo P; Lindor KD
    Am J Gastroenterol; 2005 Jun; 100(6):1330-3. PubMed ID: 15929765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome.
    Keaveny AP; Gordon FD; Goldar-Najafi A; Lewis WD; Pomfret EA; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2004 Jan; 10(1):115-22. PubMed ID: 14755787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary sclerosing cholangitis following major burn.
    Ben-Ari Z; Levingston D; Weitzman E; Haviv-Yadid Y; Cohen-Ezra O; Weiss P; Zuckerman E; Inbar Y; Amitai M; Rimon U; Goder M; Haik J
    Ann Hepatol; 2015; 14(5):695-701. PubMed ID: 26256898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Transplant in Patients with Primary Sclerosing Cholangitis: Long-Term Experience of a Single Center.
    Astarcioglu I; Egeli T; Unek T; Akarsu M; Sagol O; Obuz F; Ozbilgin M; Aysal Agalar A; Ağalar C
    Exp Clin Transplant; 2018 Aug; 16(4):434-438. PubMed ID: 30060730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.
    Voigtländer T; Leuchs E; Vonberg RP; Solbach P; Manns MP; Suerbaum S; Lankisch TO
    J Infect; 2015 May; 70(5):483-90. PubMed ID: 25659761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.
    Schwarz S; Lang C; Harlander M; Štupnik T; Slambrouck JV; Ceulemans LJ; Ius F; Gottlieb J; Kuhnert S; Hecker M; Aigner C; Kneidinger N; Verschuuren EA; Smits JM; Tschernko E; Schaden E; Faybik P; Markstaller K; Trauner M; Jaksch P; Hoetzenecker K
    J Heart Lung Transplant; 2022 Oct; 41(10):1501-1510. PubMed ID: 35907758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T; Pannicke N; Dechene A; Gotthardt DN; Kirchner G; Reiter FP; Sterneck M; Herzer K; Lenzen H; Rupp C; Barg-Hock H; de Leuw P; Teufel A; Zimmer V; Lammert F; Sarrazin C; Spengler U; Rust C; Manns MP; Strassburg CP; Schramm C; Weismüller TJ;
    Liver Transpl; 2016 Jan; 22(1):42-52. PubMed ID: 26438008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis-a study protocol for a multicenter, randomized, controlled parallel group trial.
    Stahl K; Klein F; Voigtländer T; Großhennig A; Book T; Müller T; Wree A; Kuellmer A; Weigt J; Dechene A; Wedi E; Kandulski A; Lange CM; Holzwart D; von Witzendorff D; Ringe KI; Wedemeyer H; Heidrich B;
    Trials; 2023 Mar; 24(1):247. PubMed ID: 37004078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
    Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
    Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?
    Bartoli A; Cursaro C; Seferi H; Andreone P
    Hepat Med; 2023; 15():93-112. PubMed ID: 37547355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience.
    Mizuta K; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Yamada N; Okada N; Egami S; Hishikawa S; Hyodo M; Sakuma Y; Fujiwara T; Kawarasaki H; Yasuda Y
    Transplant Proc; 2012 Mar; 44(2):469-72. PubMed ID: 22410047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.